Table 1.

Mean cell and killing data in relative, patient and control groups.

Donor groups	n	Natural killing activity	NK cells (%)	B cells (%)	T cells (%)	Lymphocytes (× 10-6/ml)	Monocytes (× 10-6/ml)
CON-M	(11)	0.83 ± 0.18	17.5 ± 7.6	13.1 ± 3.9	69.4 ± 7.0	2.29 ± 0.50	0.44 ± 0.15
CON-F	(18)	0.73 ± 0.29	14.4 ± 5.9	12.2 ± 3.2	73.4 ± 5.1	1.87 ± 0.46	0.42 ± 0.15
REL-M	(14)	0.78 ± 0.45	18.5 ± 11.2	15.6 ± 5.7	65.9 ± 10.6	2.02 ± 0.50	0.49 ± 0.17
REL-F	(31)	0.70 ± 0.32	14.5 ± 5.3	16.5 ± 5.9	69.0 ± 8.2	1.92 ± 0.73	0.44 ± 0.16
SLE-M	(5)	0.27 ± 0.17	12.4 ± 4.9	15.4 ± 10.2	72.2 ± 11.0	1.35 ± 0.51	0.43 ± 0.29
SLE-F	(60)	0.43 ± 0.33	8.3 ± 5.9	13.5 ± 8.8	78.2 ± 10.6	1.40 ± 0.67	0.46 ± 0.23
RA-M	(4)	0.82 ± 0.28	20.4 ± 6.5	12.7 ± 3.5	66.8 ± 4.5	1.31 ± 0.51	0.45 ± 0.19
RA-F	(17)	0.59 ± 0.39	11.2 ± 6.0	13.1 ± 5.9	75.7 ± 10.6	1.68 ± 0.67	0.55 ± 0.33

Mean values are given ± SD. Lymphocyte and monocyte blood counts were determined in our associated pathology laboratories. Donor groups are shown with the number of subjects in parentheses. For some groups the number in particular columns was 1 or 2 less than this. Numbering the data columns 1-6 from the left, the lower values of n were as follows: CON-F, n = 16 (columns 5 and 6); REL-F, 30 (2-6); SLE-M, 4 (1,5,6); SLE-F, 58(2-4); RA-F, 16(2-4).